Hay Fever - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Hay Fever > What Your Doctor is Reading About Hay Fever > Clinical Trials

Clinical Trials

1. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial.

Author: Tamura M; Shikina T; Morihana T; Hayama M; Kajimoto O; Sakamoto A; Kajimoto Y; Watanabe O; Nonaka C; Shida K; Nanno M;
Institution: Department of Otolaryngology and Sensory Organ Surgery, Osaka University School of Medicine, Osaka, Japan. mtamua@ent.osaka-u.ac.jp
Journal: Int Arch Allergy Immunol. 2007;143(1):75-82. Epub 2006 Dec 29.
Abstract URL: Click here to view abstract

2. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.

Author: Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D;
Institution: Department of Pediatric Allergy and Asthma, Gazi University Faculty of Medicine, Ankara, Turkey. cemrazi2@superonline.com
Journal: Ann Allergy Asthma Immunol. 2006 Dec;97(6):767-74.
Abstract URL: Click here to view abstract

3. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.

Author: Worm M;
Institution: Allergie-Centrum Charite, Klinik fur Dermatologie und Allergologie Universitatsmedizin Berlin, Universitatsklinikum Charite, Charite-Platz 1, D-10117 Berlin.
Journal: Allerg Immunol (Paris). 2006 Dec;38(10):355-60.
Abstract URL: Click here to view abstract

4. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.

Author: Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
Institution: Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, USA. pcretic@jhmi.edu
Journal: N Engl J Med. 2006 Oct 5;355(14):1445-55.
Abstract URL: Click here to view abstract

5. Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study.

Author: Rak S; Yang WH; Pedersen MR; Durham SR;
Institution: Section of Allergy, Sahlgrenska University Hospital, Goteborg, Sweden. sabina.rak@medfak.gu.se
Journal: Qual Life Res. 2007 Mar;16(2):191-201. Epub 2006 Oct 11.
Abstract URL: Click here to view abstract

6. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.

Author: Berger W; Hampel F Jr; Bernstein J; Shah S; Sacks H; Meltzer EO;
Institution: Southern California Research, Mission Viejo 92691, USA. weberger@uci.edu
Journal: Ann Allergy Asthma Immunol. 2006 Sep;97(3):375-81.
Abstract URL: Click here to view abstract

7. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study.

Author: Nathan RA; Finn AF Jr; LaForce C; Ratner P; Chapman D; de Guia EC; Hewlett D; Kramer B;
Institution: Asthma and Allergy Associates, Colorado Springs 80907, USA. DrRNathan@aol.com
Journal: Ann Allergy Asthma Immunol. 2006 Sep;97(3):389-96.
Abstract URL: Click here to view abstract

8. Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study.

Author: Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML; Bruno ME; Falagiani P; Riva G;
Institution: Clinical Allergy Immunology Center, CAIC, Lisbon, Portugal.
Journal: Allergol Immunopathol (Madr). 2006 Sep-Oct;34(5):194-8.
Abstract URL: Click here to view abstract

9. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial.

Author: Xiao JZ; Kondo S; Yanagisawa N; Takahashi N; Odamaki T; Iwabuchi N; Miyaji K; Iwatsuki K; Togashi H; Enomoto K; Enomoto T;
Institution: Food Research and Development Laboratory, Morinaga Milk Industry Co Ltd, Zama, Japan. j_xiao@morinagamilk.co.jp
Journal: Clin Exp Allergy. 2006 Nov;36(11):1425-35.
Abstract URL: Click here to view abstract

10. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis.

Author: Ratner PH; Wingertzahn MA; van Bavel JH; Hampel F; Darken PF; Shah T;
Institution: Sylvana Research, Department of Pediatrics, University of Texas Health Science Center, San Antonio, TX 78229, USA. phratner@swbell.net <phratner@swbell.net>
Journal: J Allergy Clin Immunol. 2006 Nov;118(5):1142-8. Epub 2006 Sep 25.
Abstract URL: Click here to view abstract

11. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study.

Author: Vervloet D; Birnbaum J; Laurent P; Hugues B; Fardeau MF; Massabie-Bouchat YP; Aferiat-Derome A; Andre C;
Institution: UPRES EA 3287, Service de Pneumologie, Hopital Sainte-Marguerite, Marseille, France.
Journal: Int Arch Allergy Immunol. 2007;142(3):239-46. Epub 2006 Nov 15.
Abstract URL: Click here to view abstract

12. Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis.

Author: Ratner PH; Wingertzahn MA; van Bavel JH; Hampel F; Darken PF; Hellbardt S; Brookman S; Shah T;
Institution: Sylvana Research, San Antonio, Texas 78229, USA. phratner@swbell.net
Journal: Ann Allergy Asthma Immunol. 2006 Nov;97(5):657-63.
Abstract URL: Click here to view abstract

13. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.

Author: Pradalier A; Neukirch C; Dreyfus I; Devillier P; Pradalier A; Neukirch C; Dreyfus I; Devillier P;
Institution: Department of Internal Medicine, Hopital Louis Mourier, Colombes Cedex, France.
Journal: Allergy. 2007 Nov;62(11):1331-4. Epub 2007 May 23.
Abstract URL: Click here to view abstract

14. Healthcare professional versus patient goal setting in intermittent allergic rhinitis.

Author: O'Connor J; Seeto C; Saini B; Bosnic-Anticevich S; Krass I; Armour C; Smith L;
Institution: The University of Sydney, Sydney, Australia.
Journal: Patient Educ Couns. 2008 Jan;70(1):111-7. Epub 2007 Nov 7.
Abstract URL: Click here to view abstract

15. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis.

Author: Casale TB; Romero FA; Spierings EL;
Institution: Division of Allergy and Immunology, Department of Medicine, Creighton University, Omaha, NE 68131, USA. tbcasale@creighton.edu
Journal: J Allergy Clin Immunol. 2008 Jan;121(1):105-9. Epub 2007 Oct 29.
Abstract URL: Click here to view abstract

16. An assessment of the onset and duration of action of olopatadine nasal spray.

Author: Patel P; Roland PS; Marple BF; Benninger PJ; Margalias H; Brubaker M; Beezley SF; Drake M; Potts SL; Wall GM;
Institution: Allied Research International, Mississauga, ON, Canada. ppatel@allied-research.com
Journal: Otolaryngol Head Neck Surg. 2007 Dec;137(6):918-24.
Abstract URL: Click here to view abstract

17. Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study.

Author: de Blay F; Barnig C; Kanny G; Purohit A; Leynadier F; Tunon de Lara JM; Chabane H; Guerin L; de Blay F; Barnig C; Kanny G; Purohit A; Leynadier F; Tunon de Lara JM; Chabane H; Guerin L;
Institution: Departement de Pneumologie, Hopital Lyautey, Hopitaux Universitaires de Strasbourg, Strasbourg, France. frederic.deblay@chru-strasbourg.fr
Journal: Ann Allergy Asthma Immunol. 2007 Nov;99(5):453-61.
Abstract URL: Click here to view abstract

18. Sublingual immunotherapy in pollen-induced seasonal rhinitis and conjunctivitis: a randomized controlled trial.

Author: Mosges R; Bruning H; Hessler HJ; Gotz G; Knaussmann HG; Mosges R; Bruning H; Hessler HJ; Gotz G; Knaussmann HG;
Institution: IMSIE - Klinikum der Universitat zu Koln, D-50924 Cologne, Germany. ralph@moesges.de
Journal: Acta Dermatovenerol Alp Panonica Adriat. 2007 Dec;16(4):143-8.
Abstract URL: Click here to view abstract

19. Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis.

Author: Widegren H; Erjefalt J; Korsgren M; Andersson M; Greiff L;
Institution: Department of Otorhinolaryngology, Head & Neck Surgery, Lund University Hospital, Lund, Sweden. henrik.widegren@skane.se
Journal: Respir Res. 2008 Jan 30;9:15.
Abstract URL: Click here to view abstract

20. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire.

Author: Valero A; Alonso J; Antepara I; Baro E; Colas C; del Cuvillo A; Ferrer M; Herdman M; Marti-Guadano E; Monclus L; Mullol J; Navarro-Pulido AM; Navas C; Sastre J; Baltasar M; Bartra J; Serrano C; Cardona V; Castillo JA; Cerda MT; Cistero A; Conejero A; Davila I; Escudero C; Hernandez E; Vereda A; Fernandez B; Mencia J; Fernandez J; Florido J; Quiralte J; Guardia P; Malek T; Montoro J; Orta JC; Oehling A; Pascual MJ; de la Parte B; Raga E; Rubira N; Ranea S; Rivas P; Serra J; Tabar A;
Institution: Unidad de Alergia, Servicio de Neumologia y Alergia Respiratoria, Hospital Clinic i Provincial, C. Villarroel, 170, 08036 Barcelona, Spain. valero@clinic.ub.es
Journal: Value Health. 2007 Nov-Dec;10(6):466-77.
Abstract URL: Click here to view abstract

21. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

Author: Jacobsen L; Niggemann B; Dreborg S; Ferdousi HA; Halken S; Host A; Koivikko A; Norberg LA; Valovirta E; Wahn U; Moller C;
Institution: ALK-Abello, Horsholm, Denmark.
Journal: Allergy. 2007 Aug;62(8):943-8.
Abstract URL: Click here to view abstract

22. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.

Author: Durham SR; Riis B;
Institution: National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.
Journal: Allergy. 2007 Aug;62(8):954-7.
Abstract URL: Click here to view abstract

23. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.

Author: Calderon MA; Birk AO; Andersen JS; Durham SR;
Institution: Imperial College, National Heart and Lung Institute, London, UK.
Journal: Allergy. 2007 Aug;62(8):958-61.
Abstract URL: Click here to view abstract

24. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.

Author: Klunker S; Saggar LR; Seyfert-Margolis V; Asare AL; Casale TB; Durham SR; Francis JN;
Institution: Upper Respiratory Medicine, Section of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, United Kingdom.
Journal: J Allergy Clin Immunol. 2007 Sep;120(3):688-95. Epub 2007 Jul 12.
Abstract URL: Click here to view abstract

25. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.

Author: Ibanez MD; Kaiser F; Knecht R; Armentia A; Schopfer H; Tholstrup B; Bufe A;
Institution: Servicio de Alergia, Hospital Universitario Nino Jesus, Madrid, Spain. dibanezs@medynet.com
Journal: Pediatr Allergy Immunol. 2007 Sep;18(6):516-22.
Abstract URL: Click here to view abstract

26. Peak expiratory flow monitoring to screen for asthma in patients with allergic rhinitis.

Author: Baser S; Ozkurt S; Topuz B; Kiter G; Karabulut H; Akdag B; Evyapan F;
Institution: Pamukkale University Medical Faculty, Department of Pulmonary Diseases, Denizli, Turkey. basersevin@yahoo.com
Journal: J Investig Allergol Clin Immunol. 2007;17(4):211-5.
Abstract URL: Click here to view abstract

27. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.

Author: Powell RJ; Frew AJ; Corrigan CJ; Durham SR; Powell RJ; Frew AJ; Corrigan CJ; Durham SR;
Institution: Clinical Immunology Unit, University Hospital, Queens Medical Centre, Nottingham, UK.
Journal: Allergy. 2007 Nov;62(11):1335-8. Epub 2007 Aug 21.
Abstract URL: Click here to view abstract

28. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.

Author: Lumry W; Prenner B; Corren J; Wheeler W;
Institution: AARA Research Center, Dallas, Texas 75231, USA. lumrymd@sbcglobal.net
Journal: Ann Allergy Asthma Immunol. 2007 Sep;99(3):267-72.
Abstract URL: Click here to view abstract

29. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

Author: Didier A; Malling HJ; Worm M; Horak F; Jager S; Montagut A; Andre C; de Beaumont O; Melac M; Didier A; Malling HJ; Worm M; Horak F; Jager S; Montagut A; Andre C; de Beaumont O; Melac M;
Institution: Department of Pneumology, Larrey Hospital, Toulouse, France. Didier.a@chu-toulouse.fr
Journal: J Allergy Clin Immunol. 2007 Dec;120(6):1338-45. Epub 2007 Nov 1.
Abstract URL: Click here to view abstract

30. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.

Author: Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H; Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H;
Institution: Sylvana Research, San Antonio, Texas, USA.
Journal: Ann Allergy Asthma Immunol. 2008 Jan;100(1):74-81.
Abstract URL: Click here to view abstract

31. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis.

Author: Garavello W; Di Berardino F; Romagnoli M; Sambataro G; Gaini RM;
Institution: Department of Otorhinolaryngology, University Milano-Bicocca, Monza, Italy. werner.garavello@unimib.it
Journal: Int Arch Allergy Immunol. 2005 Aug;137(4):310-4. Epub 2005 Jun 20.
Abstract URL: Click here to view abstract

32. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.

Author: Mucha SM; deTineo M; Naclerio RM; Baroody FM;
Institution: Section of Otolaryngology-Head and Neck Surgery, The Pritzker School of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Journal: Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):164-72.
Abstract URL: Click here to view abstract

33. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis.

Author: Nave R; Wingertzahn MA; Brookman S; Kaida S; Matsunaga T;
Institution: ALTANA Pharma AG, Byk-Gulden-Str. 2, 78467 Konstanz, Germany.
Journal: J Clin Pharmacol. 2006 Apr;46(4):461-7.
Abstract URL: Click here to view abstract

34. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Author: Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S;
Institution: Royal Brompton and Harefield Hospitals National Health Service Trust and Imperial College, National Heart and Lung Institute, London, United Kingdom. s.durham@imperial.ac.uk
Journal: J Allergy Clin Immunol. 2006 Apr;117(4):802-9.
Abstract URL: Click here to view abstract

35. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.

Author: Colas C; Monzon S; Venturini M; Lezaun A;
Institution: Servicio de Alergia, Hospital Clinico Lozano Blesa, Zaragoza, Spain. algc-colas@hcu-lblesa.es
Journal: J Allergy Clin Immunol. 2006 Apr;117(4):810-6. Epub 2006 Feb 8.
Abstract URL: Click here to view abstract

36. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.

Author: Parameswaran K; Fanat A; O'Byrne PM;
Institution: Firestone Institute for Respiratory Health, St Joseph's Healthcare, and Department of Medicine, McMaster University, Hamilton, Canada.
Journal: Allergy. 2006 Jun;61(6):731-6.
Abstract URL: Click here to view abstract

37. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.

Author: Price DB; Swern A; Tozzi CA; Philip G; Polos P;
Institution: Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Aberdeen UK.
Journal: Allergy. 2006 Jun;61(6):737-42.
Abstract URL: Click here to view abstract

38. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults.

Author: Emberlin JC; Lewis RA;
Institution: National Pollen and Aerobiology Research Unit, Institute of Health, University of Worcester, Worcester, WR2 6AJ, UK. j.emberlin@worc.ac.uk
Journal: Curr Med Res Opin. 2006 Feb;22(2):275-85.
Abstract URL: Click here to view abstract

39. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.

Author: Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
Institution: Allergy & Inflammation Research Subdivision, School of Medicine, University of Southampton, UK. ajf@eaaci.org
Journal: J Allergy Clin Immunol. 2006 Feb;117(2):319-25.
Abstract URL: Click here to view abstract

40. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.

Author: Ratner P; Falques M; Chuecos F; Esbri R; Gispert J; Peris F; Luria X; Rosales MJ;
Institution: Sylvana Research Associates, San Antonio, Texas, USA.
Journal: Int Arch Allergy Immunol. 2005 Dec;138(4):312-8. Epub 2005 Oct 11.
Abstract URL: Click here to view abstract

41. Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis.

Author: Berger WE; Nayak AS; Staudinger HW;
Institution: Department of Pediatrics, Division of Allergy and Immunology, University of California, Irvine, 92691, USA. werber@uci.edu
Journal: Ann Pharmacother. 2005 Dec;39(12):1984-9. Epub 2005 Nov 8.
Abstract URL: Click here to view abstract

42. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.

Author: Dahl R; Stender A; Rak S;
Institution: Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark.
Journal: Allergy. 2006 Feb;61(2):185-90.
Abstract URL: Click here to view abstract

43. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.

Author: Chervinsky P; Nayak A; Rooklin A; Danzig M;
Institution: Northeast Medical Research Associates, 49 State Road, Suite 203, North Dartmouth, MA 02747, USA.
Journal: Allergy Asthma Proc. 2005 Sep-Oct;26(5):391-6.
Abstract URL: Click here to view abstract

44. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.

Author: Roberts G; Hurley C; Turcanu V; Lack G;
Institution: University Child Health, University of Southampton, Hants, UK. g.c.roberts@soton.ac.uk
Journal: J Allergy Clin Immunol. 2006 Feb;117(2):263-8.
Abstract URL: Click here to view abstract

45. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.

Author: Raphael GD; Angello JT; Wu MM; Druce HM;
Institution: Pfizer Consumer Healthcare, Morris Plains, New Jersey 07950, USA.
Journal: Ann Allergy Asthma Immunol. 2006 Apr;96(4):606-14.
Abstract URL: Click here to view abstract

46. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.

Author: Hampel FC Jr; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM;
Institution: Central Texas Health Research, New Braunfels and San Antonio, Texas, 78130, USA. fchampel@aol.com
Journal: Allergy Asthma Proc. 2006 May-Jun;27(3):202-7.
Abstract URL: Click here to view abstract

47. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

Author: Berger WE; Lumry WR; Meltzer EO; Pearlman DS;
Institution: Allergy and Asthma Associates of Southern California, Mission Viejo, California 92691, USA. WEBerger@uci.edu
Journal: Allergy Asthma Proc. 2006 May-Jun;27(3):214-23.
Abstract URL: Click here to view abstract

48. Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient?

Author: Can D; Tanac R; Demir E; Gulen F; Veral A;
Institution: Division of Pediatric Allergy and Pulmonology, Behcet Uz Children Hospital, Izmir, Turkey. ddcan15@hotmail.com
Journal: Allergy Asthma Proc. 2006 May-Jun;27(3):248-53.
Abstract URL: Click here to view abstract

49. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.

Author: Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Sackesen C; Kalayci O;
Institution: Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Hacettepe, Ankara, Turkey.
Journal: Pediatr Allergy Immunol. 2006 Sep;17(6):396-407.
Abstract URL: Click here to view abstract

50. Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis.

Author: Bordignon V; Burastero SE;
Institution: Bassano del Grappa (VI), Italy.
Journal: Ann Allergy Asthma Immunol. 2006 Aug;97(2):158-63.
Abstract URL: Click here to view abstract

51. Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study.

Author: Larsen TH; Poulsen LK; Melac M; Combebias A; Andre C; Malling HJ;
Institution: Allergy Clinic, National University Hospital, Copenhagen, Denmark.
Journal: Allergy. 2006 Oct;61(10):1173-6.
Abstract URL: Click here to view abstract

52. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.

Author: Valovirta E; Jacobsen L; Ljorring C; Koivikko A; Savolainen J;
Institution: Turku Allergy Centre, Turku, Finland.
Journal: Allergy. 2006 Oct;61(10):1177-83.
Abstract URL: Click here to view abstract

53. Levocetirizine as treatment for symptoms of seasonal allergic rhinitis.

Author: Jorissen M; Bertrand B; Stiels B; Vandenbulcke K;
Institution: Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leuven, Belgium.
Journal: B-ENT. 2006;2(2):55-62.
Abstract URL: Click here to view abstract

54. Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis.

Author: Pitsios C; Papadopoulos D; Kompoti E; Manoussakis E; Garris V; Petalas K; Tassios I; Baibas N; Kontou-Fili K; Saxoni-Papageorgiou P; Papadopoulos NG;
Institution: Department of Allergology and Clinical Immunology, Laikon General Hospital, Athens, Greece.
Journal: Ann Allergy Asthma Immunol. 2006 May;96(5):673-8.
Abstract URL: Click here to view abstract

55. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?

Author: Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE;
Institution: Hacettepe University Faculty of Medicine, Pediatric Allergy and Asthma Unit, Hacettepe, Ankara, Turkey.
Journal: Pediatr Allergy Immunol. 2006 Jun;17(4):259-68.
Abstract URL: Click here to view abstract

56. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.

Author: Malling HJ; Lund L; Ipsen H; Poulsen L;
Institution: Allergy Clinic, National University Hospital, Copenhagen, Denmark. hans.joergen.malling@rh.hosp.dk
Journal: J Investig Allergol Clin Immunol. 2006;16(3):162-8.
Abstract URL: Click here to view abstract

57. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.

Author: Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE;
Institution: Southwest Allergy and Asthma Research, San Antonio, Texas 78229, USA. swallergy@sbcglobal.net
Journal: Ann Allergy Asthma Immunol. 2006 Jun;96(6):851-7.
Abstract URL: Click here to view abstract

58. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.

Author: Cordray S; Harjo JB; Miner L;
Institution: Academic Programs at Southern Nazarene University, Tulsa, Okla, USA. scordray@cfaith.com
Journal: Ear Nose Throat J. 2005 Jul;84(7):426-30.
Abstract URL: Click here to view abstract

59. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

Author: Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Rivas MF; Ribel M; Durham SR;
Institution: Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark.
Journal: J Allergy Clin Immunol. 2006 Aug;118(2):434-40.
Abstract URL: Click here to view abstract